IFNG and Miyoshi myopathy: Panobinostat impaired MM cell viability; however, IFN-γ did not further affect and lenalidomide or pomalidomide marginally or only weakly suppressed the viability of the MM cells in combination with panobinostat (Supplementary Figure 4B).